Exclusive Educo Life Sciences Training for Bayer – Information and Registration Page
Advanced Therapies Training Course
Next Running in February/March 2026 (24, 26 Feb & 3, 5 Mar)
Exclusive Training Partnership with Educo Life Sciences for Bayer Employees
Secure Your Spot – Sign Up Today
To register for this exclusive course:
✔ Learn more about the course below.
✔ Register for this course by completing the form.
✔ Once registered, we will send a secure payment link through email.
✔ If the next delivery is full we will keep you on a waiting list for the next delivery.
- For USD $260 per person
- For EUROs €244 per person
- For GBP £195 per person
** Prices may change depending on the number of registrations**
Complete the Form Below
Course Overview
Join this exclusive, expert-led training designed specifically for Bayer. This interactive programme will enhance your expertise in Cell Therapies, with a deep dive into autologous and allogeneic approaches, while distinguishing them from traditional biologics and monoclonal antibodies.
Gain hands-on insights into cutting-edge technologies, regulatory landscapes, and critical manufacturing processes. This comprehensive training will equip you with the knowledge and skills to drive innovation in advanced therapies, ensuring you stay ahead in this rapidly evolving field.
Once completed, you will receive a digital certificate which you can share on your LinkedIn profile or download as a PDF.
Course Agenda
To be Delivered in February and March 2026
Module 1 – Understanding Biologics and CGTs
24 February 2026 | 3 Hours | 9:30 AM to 12:30 PM (PT)
This module introduces biologics and cell & gene therapies (CGTs), differentiating them from small molecules. It covers autologous vs. allogeneic therapies, stem cell sources, the fragility of cells, key quality attributes, emerging technologies, and gene editing.
- Differences between Biologics and Small Molecules
- What are Cell & Gene Therapies?
- Distinction Autologous vs. Allogeneic
- MSC, HSC, iPSC – Evaluating the Suitability
- Which one should I use?
- What source of stem cell?
- The Fragility of the Cell
- The CQA Pyramid of Thought
- Emerging Products
- Technology Overview including mRNA & LNP
- Gene Editing
Module 2 – Manufacture of Cell & Gene Therapies (CMC)
26 February 2026 | 3 Hours | 9:30 AM to 12:30 PM (PT)
This module explores the chemistry, manufacturing, and controls (CMC) for CGTs, highlighting the challenges in scaling up, the role of CDMOs, critical raw materials, quality assurance, and analytical considerations for ensuring product consistency and regulatory compliance.
- The Manufacturing Landscape
- CDMO Services
- Technologies applied to Cell & Gene Therapy
- Review of ATMP CMC / Cell Therapy CMC Manufacture Processes
- Importance of Materials
- Donor Selection
- Cytokine use
- Buffers/Media/Reagents
- Importance of Analytics
- The DMP (Decision Making Process) of Analytics – the Eyes of the Dossier
- EU/US Guidance
Module 3 – Importance of Quality
3 March 2026 | 3 Hours | 9:30 AM to 12:30 PM (PT)
Focusing on quality assurance in CGTs, this module examines GMP regulations, risk-based approaches, documentation requirements, and the challenges of ensuring comparability, stability, and analytical integrity in CGT development.
- Understanding Quality and Impact for CGTs
- The GMP Guidance and GMP Questions
- What is and When to introduce GMP Risk Based Approach
- Examples of ATMPs
- QA Responsibilities
- The Quality Dilemma
- The need to create effective Documentation
- The CTD data for a CGT
- IND/IMPD Content – Phase Dependent
- Comparability
- Comparability assessment
- Review the analytical studies involved
Module 4 – Regulatory Considerations
5 March 2026 | 3 Hours | 9:30 AM to 12:30 PM (PT)
Covering global regulatory frameworks, this module details US and EU regulations for advanced therapy medicinal products (ATMPs), including classifications, scientific advice processes, expedited approval pathways, and compliance with key regulatory guidelines.
- The Regulatory barriers
- US Regulations of CGT – The Office of Therapeutic Products
- EU Regulations for ATMPs – Analysis of Regulation 1394/2007
- Classifications and Certification of ATMPs in EU
- Scientific Advice
- EU Prime / US RMAT
- INTERACT / ITF meetings
- Pre-IND meetings
- Understanding Guidelines
Secure Your Spot – Sign Up Today
To register for this exclusive course:
✔ Learn more about the course below.
✔ Register for this course by completing the form.
✔ Once registered, we will send a secure payment link through email.
✔ If the next delivery is full we will keep you on a waiting list for the next delivery.
- For USD $260 per person
- For EUROs €244 per person
- For GBP £195 per person
** Prices may change depending on the number of registrations**
Complete the Form Below
Secure Your Spot – Sign Up Today
To register for this exclusive course:
✔ Learn more about the course below
✔ Register for this course by completing the form
✔ We will send you a payment link to complete your registration
✔ The price is dependent on the number of registrations
The price per person is dependent on the total number attending the course (the more sign-ups the lower the cost)
- Up to 20 > £300 / $390 / €365
- 21 to 40 > £200 / $260 / €244